Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DJR71Z
|
|||
| Drug Name |
ALMB-0166
|
|||
| Indication | Spinal cord injury [ICD-11: ND51.2] | Phase 1 | [1] | |
| Company |
AlaMab Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05524103) A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ALMB-0166 in Patients With Acute Spinal Cord Injury. U.S.National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of AlaMab Therapeutics | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.